PRAC Antikörper (N-Term)
-
- Target Alle PRAC Antikörper anzeigen
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PRAC Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified
- Immunogen
- PRAC antibody was raised in rabbit using the N terminal of PRAC as the immunogen
- Top Product
- Discover our top product PRAC Primärantikörper
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator.
- Kommentare
-
PRAC Blocking Peptide, catalog no. 33R-2130, is also available for use as a blocking control in assays to test for specificity of this PRAC antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
- Andere Bezeichnung
- PRAC (PRAC Produkte)
- Synonyme
- C17orf92 antikoerper, PRAC antikoerper, PRAC1 small nuclear protein antikoerper, PRAC1 antikoerper
- Hintergrund
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus. Synonyms: Polyclonal PRAC antibody, Anti-PRAC antibody, prostate cancer susceptibility candidate antibody, C17orf92 antibody, MGC32520 antibody.
-